12 Amendments of Annie SCHREIJER-PIERIK related to 2018/2108(INI)
Amendment 50 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. Whereas NCPs are not yet sufficiently well known to the public, which has an impact on their effectiveness;
Amendment 58 #
Motion for a resolution
Recital M
Recital M
M. whereas the directive will only be effective if patients, carers, healthcare professionals and other stakeholders are well informed about it;
Amendment 61 #
Motion for a resolution
Recital N
Recital N
N. whereas patients, carers and healthcare professionals are still encountering a large information gap regarding patients’ rights under the directive;
Amendment 66 #
Motion for a resolution
Recital O
Recital O
O. whereas there is considerable room for improvement in the reimbursement procedures in a number of Member States, including for orphan drugs and pharmaceutically compounded medicinal products;
Amendment 69 #
Motion for a resolution
Recital Q a (new)
Recital Q a (new)
Q a. whereas a growing number of citizens of the Union desire unimpaired access to and make use of preventive medical tests, scans and health checks available in other Member States;
Amendment 89 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Expresses serious concern about the proposed reduction in funding for the health programme; reiterates its call for the health programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027), in order to implement the UN Sustainable Development Goals (SDGs) on public health, health systems and environment- related problems, and ensure an ambitious health policy with a focus on cross-border challenges, including, in particular, a considerable increase in common EU efforts in the fight against cancer, the prevention and detection of chronic and rare diseases, combating anti-microbial resistance and ensuring easier access to cross-border healthcare;
Amendment 93 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Notes that the reasons for low patient mobility are threfivefold: i) some Member States were quite late implementing the directive; ii) citizens’ awareness about their general rights to reimbursement is extremely low and iii; iii) insurance companies have been using the lack of citizens' awareness to their advantage; iv) Member States have transposed the directive in ways that could be construed as limiting cross-border healthcare and v) barriers to cross-border healthcare such as upfront payments, have meant that the use of this directive depends to a large degree on personal wealth;
Amendment 99 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Draws the Commission’s attention to the fact that advance payments for patients receiving cross-border healthcare can form a social barrier and should be avoided where possible;
Amendment 104 #
Motion for a resolution
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Notes with concern that in some Member States insurance companies have discriminated arbitrarily or created unjustified obstacles to the free movement of patients and services, with adverse financial consequences for patients;
Amendment 116 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12 a. Notes with concern that in certain Member States policies and legal provisions are under discussion, in the context of regulating population screening, which would introduce additional requirements to license preventive medical tests, scans and health checks carried out in other Member States; asks the Commission to defend the freedom of citizens in the Union to provide or receive services1a and actively monitor ongoing developments in Member States in this field; _________________ 1a Art. 56 TFEU.
Amendment 128 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Calls on the Commission and the Member States to invest further in the development and promotion of highly accessible and clearly visible NCPs which provide user- friendly information for patients, carers and health professionals;
Amendment 163 #
Motion for a resolution
Paragraph 25 a (new)
Paragraph 25 a (new)
25a. Calls on the Commission to draw up an action plan to systematically address excessively high medicine prices and the large disparities in them between the various Member States;